Oxidative stress in Alzheimer disease

Neurodegenerative diseases and oxidative stress

Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683

Protein Oxidation in Aging, Disease, and Oxidative Stress

Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,379

[37] Carbonyl assays for determination of oxidatively modified proteins

Levine, R. L., Williams, J. A., Stadtman, E. R., & Shacter, E. B. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)33040-9 · Cited by 2,707

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885

The oxidative environment and protein damage

Davies, M. J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.08.007 · Cited by 1,392

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,256

Oxidative stress and Alzheimer disease

Christen, Y. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,176

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

Schmidt, A. M., Yan, S. D., Yan, S. F., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200114002 · Cited by 1,039

Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease

Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037

4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

Sayre, L., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,032

Oxidative damage in Alzheimer's

Smith, M. A., Perry, G. L., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. W. (1996) · Nature · doi:10.1038/382120b0 · Cited by 897

Oxidative Stress and Neurotoxicity

Sayre, L. M., Perry, G. L., & Smith, M. A. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 884

Protein carbonylation, cellular dysfunction, and disease progression

Dalle‐Donne, I., Aldini, G., Carini, M., Colombo, R., Rossi, R., & Milzani, A. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00407.x · Cited by 857

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806

A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide

Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781

RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

Nunomura, A., Perry, G., Pappolla, M., Wade, R., Hirai, K., Chiba, S., & Smith, M. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01959.1999 · Cited by 768

Does oxidative damage to DNA increase with age?

Hamilton, M. L., Van Remmen, H., Drake, J. A., Yang, H., Guo, Z. M., Kewitt, K., Walter, C. A., & Richardson, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171202698 · Cited by 768

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680

Oxidative Damage to DNA: Do We Have a Reliable Biomarker?

Collins, A. R., Dušinská, M., Gedik, C. M., & Štětina, R. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104s3465 · Cited by 657

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644

Identification of Glyoxal and Arabinose as Intermediates in the Autoxidative Modification of Proteins by Glucose

Wells‐Knecht, K. J., Zyzak, D. V., Litchfield, J., Thorpe, S. R., & Baynes, J. (1995) · Biochemistry · doi:10.1021/bi00011a027 · Cited by 594

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.

Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565

Type 2 diabetes mellitus, cognitive impairment and dementia

Stewart, R., & Liolitsa, D. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00027.x · Cited by 562

Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease

Lovell, M. A., & Markesbery, W. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm821 · Cited by 515

Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain.

Forster, M. J., Dubey, A., Dawson, K. M., Stutts, W. A., Lal, H., & Sohal, R. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4765 · Cited by 494

Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease

Gabbita, S. P., Lovell, M. A., & Markesbery, W. R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052034.x · Cited by 479

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs

Breitner, J. C. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00049-k · Cited by 465

Radical AGEing in Alzheimer's disease

Smith, M. A., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93897-7 · Cited by 462

Neuronal and glial calcium signaling in Alzheimer’s disease

Mattson, M. P., & Chan, S. L. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00128-3 · Cited by 459

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease

Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., & Brandt, J. (1995) · Neurology · doi:10.1212/wnl.45.1.51 · Cited by 446

Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal

Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010273.x · Cited by 439

Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

Smith, M. A., Kutty, R. K., Richey, P. L., Yan, S. D., Stern, D., Chader, G. J., Wiggert, B. O., Petersen, R. B., & Perry, G. L. (1994) · PubMed Central · Cited by 425

The Relation Between Antioxidants and Memory Performance in the Old and Very Old

Perrig, W. J., Perrig, P., & Stähelin, H. B. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb01476.x · Cited by 344

Glutathione-dependent detoxification of α-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors

Thornalley, P. J. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00157-9 · Cited by 308

Increased DNA Oxidation and Decreased Levels of Repair Products in Alzheimer's Disease Ventricular CSF

Lovell, M. A., Gabbita, S. P., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720771.x · Cited by 292

Age-related changes in glutathione and glutathione-related enzymes in rat brain

Zhu, Y., Carvey, P. M., & Ling, Z. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.063 · Cited by 279

Vitamin E and Alzheimer disease: the basis for additional clinical trials

Grundman, M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.630s · Cited by 269

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

Hoyer, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050067 · Cited by 265

Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance

Curb, J. D., Rodríguez, B. L., Abbott, R. D., Petrovitch, H., Ross, G. W., Masaki, K., Foley, D. J., Blanchette, P. L., Harris, T. B., Chen, R., et al. (1999) · Neurology · doi:10.1212/wnl.52.5.971 · Cited by 231

Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine

Smith, M. A., Sayre, L. M., Anderson, V. E., Harris, P. L. R., Beal, M. F., Kowall, N. W., & Perry, G. L. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600605 · Cited by 222

Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain

Mecocci, P., Beal, M. F., Cecchetti, R., Polidori, M. C., Cherubini, A., Chionne, F., Avellini, L., Romano, G., & Senin, U. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815160 · Cited by 215

Increased lipoprotein oxidation in alzheimer’s disease

Schippling, S., Kontush, A., Arlt, S., Buhmann, C., Stürenburg, H.-J., Mann, U. M., Müller‐Thomsen, T., & Beisiegel†, U. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00247-6 · Cited by 202

H2o2 and 4-hydroxynonenal mediate amyloid β-induced neuronal apoptosis by activating jnks and p38mapk

Tamagno, E., Robino, G., Obbili, A., Bardini, P., Aragno, M., Parola, M., & Danni, O. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00059-6 · Cited by 201

Carbonyl Toxicology and Alzheimer's Disease

Picklo, M. J. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9506 · Cited by 194

The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease

Selley, M. L. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00327-x · Cited by 176

Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type

Gsell, W., Conrad, R., Hickethier, M., Sofic, E., Frölich, L., Wichart, I., Jellinger, K. A., Moll, G. H., Ransmayr, G. N., Beckmann, H., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031216.x · Cited by 175

New biomarkers of Maillard reaction damage to proteins

Wells‐Knecht, K. J., Brinkmann, E., Wells-Knecht, M. C., Litchfield, J., Ahmed, M., Reddy, S., Zyzak, D. V., Thorpe, S. R., & Baynes, J. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.41 · Cited by 170

Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state

Calabrese, V. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.01.003 · Cited by 162

The Risk of Dementia among Persons with Diabetes Mellitus: A Population‐Based Cohort Studya

Leibson, C. L., Rocca, W. A., Hanson, V., CHA, R., Kokmen, E., O’Brien, P. C., & Palumbo, P. J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48496.x · Cited by 152

Lipid peroxidation in neurodegeneration: new insights into Alzheimerʼs disease

Arlt, S., Beisiegel†, U., & Kontush, A. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00009 · Cited by 151

Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases

Luo, Y., Bond, J. D., & Ingram, V. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9705 · Cited by 141

Studies on lipid peroxidation and protein oxidation in the aging brain

Cini, M., & Moretti, A. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80007-e · Cited by 137

Metal ions and oxidative protein modification in neurological disease.

Sayre, L. M., Moreira, P. I., Smith, M. A., & Perry, G. L. (2005) · PubMed · Cited by 135

4-Hydroxynonenal, a Product of Lipid Peroxidation, Damages Cholinergic Neurons and Impairs Visuospatial Memory in Rats

Bruce‐Keller, A. J., Li, Y., Lovell, M. A., Kraemer, P. J., Gary, D. S., Brown, R. R., Markesbery, W. R., & Mattson, M. P. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199803000-00007 · Cited by 133

Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A

Arendt, T., Holzer, M., Fruth, R., Brückner, M. K., & Gärtner, U. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00347-l · Cited by 132

Free radicals in Alzheimer’s disease

Retz, W., Gsell, W., Münch, G. W., Rösler, M., & Riederer, P. F. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_22 · Cited by 125

Alterations in oxidative stress scavenger system in aging rat brain and lymphocytes

Sandhu, S. K., & Kaur, G. (2002) · Biogerontology · doi:10.1023/a:1015643107449 · Cited by 115

Ascorbic acid-induced crosslinking of lens proteins: evidence supporting a Maillard reaction

ORTWERTH, B. J., & Olesen, P. R. (1988) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(88)90292-0 · Cited by 115

The Effect of Aging on Glutathione and Cysteine Levels in Different Regions of the Mouse Brain

Chen, T. S., Richie, J. P., & Lang, C. A. (1989) · Experimental Biology and Medicine · doi:10.3181/00379727-190-42879 · Cited by 110

Transition metal‐mediated glycoxidation accelerates cross‐linking of β‐amyloid peptide

Loske, C., Gerdemann, A., Schepl, W., Wycislo, M., Schinzel, R., Palm, D., Riederer, P. F., & Münch, G. W. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01452.x · Cited by 108

Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain

Ramassamy, C., Krzywkowski, P., Averill‐Bates, D. A., Lussier‐Cacan, S., Théroux, L., Christen, Y., Davignon, J., & Poirier, J. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00268-0 · Cited by 96

Gender difference in glutathione metabolism during aging in mice

Wang, H. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00036-6 · Cited by 89

Investigations on oxidative stress and therapeutical implications in dementia

Durany, N., Münch, G. W., Michel, T. M., & Riederer, P. F. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014177 · Cited by 86

Multiplexed Proteomic Analysis of Oxidation and Concentrations of Cerebrospinal Fluid Proteins in Alzheimer Disease

Korolainen, M. A., Nyman, T. A., Nyyssönen, P., Hartikainen, S., & Pirttilä, T. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.078014 · Cited by 85

Age-associated changes in protein oxidation and proteasome activities in rat brain: Modulation by antioxidants

Mohsen, M. M. A. E., Iravani, M. M., Spencer, J. P. E., Rose, S., Fahim, A. T., Motawi, T. K., Ismail, N. A. F., & Jenner, P. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.201 · Cited by 83

Risk Factors for Vascular Disease and Dementia

Breteler, M. M. B., Bots, M. L., Ott, A., & Albert Hofman, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022428 · Cited by 82

Cognitive impairment and oxidative stress in the elderly: Results of epidemiological studies

Berr, C. (2000) · BioFactors · doi:10.1002/biof.5520130132 · Cited by 80

Age-Related Elevation of Lipid Peroxidation Products: Diminution of Superoxide Dismutase Activity in the Central Nervous System of Rats

Gupta, A., Hasan, M. N., Chander, R., & Kapoor, N. K. (2009) · Gerontology · doi:10.1159/000213277 · Cited by 80

Down‐regulation of γ‐glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging

Liu, R.-M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10217 · Cited by 77

Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress?

Münch, G. W., Gerlach, M., Sian, J., Wong, A. O., & Riederer, P. F. (1998) · Annals of Neurology · doi:10.1002/ana.410440713 · Cited by 73

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation

Münch, G. W., Taneli, Y., Schraven, E., Schindler, U., Schinzel, R., Palm, D., & Riederer, P. F. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260940 · Cited by 69

Lipoproteins and lipid peroxidation in Alzheimer's disease.

Bassett, C. N., & Montine, T. J. (2003) · PubMed · Cited by 67

Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease

Li, Y. M., & Dickson, D. W. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00266-8 · Cited by 62

Free radicals in Alzheimer’s dementia: currently available therapeutic strategies

Rösler, M., Retz, W., Thome, J., & Riederer, P. F. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_21 · Cited by 60

A tombstone in Alzheimer's?

Mattson, M. P., Carney, J. M., & Butterfield, D. A. (1995) · Nature · doi:10.1038/373481a0 · Cited by 59

Inhibitory Effects of Tenilsetam on the Maillard Reaction

Shoda, H., Miyata, S., Liu, B.-F., Yamada, H., Ohara, T., Suzuki, K., Oimomi, M., & Kasuga, M. (1997) · Endocrinology · doi:10.1210/endo.138.5.5151 · Cited by 59

Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease

Münch, G. W., Cunningham, A. M., Riederer, P. F., & Braak, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00328-x · Cited by 57

Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?

Blum-Degen, D., Frölich, L., Hoyer, S., & Riederer, P. F. (1995) · PubMed · Cited by 55

Alzheimer neurofibrillary lesions: Molecular nature and potential roles of different components

Yen, S.-H. C., Liu, W.-K., Hall, F. L., Yan, S., Stern, D. M., & Dickson, D. W. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00022-7 · Cited by 53

Age-related changes of glutathione content, glucose transport and metabolism, and mitochondrial electron transfer function in mouse brain

Sasaki, T., Senda, M., Kim, S.-N., Kojima, S., & Kubodera, A. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00180-3 · Cited by 46

Age and GSH metabolism in rat cerebral cortex, as related to oxidative and energy parameters

Iantomasi, T., Favilli, F., Marraccini, P., Stio, M., Treves, C., Quatrone, A., Capaccioli, S., & VINCENZINI, M. T. (1993) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(93)90060-5 · Cited by 45

Growth hormone administration to aged animals reduces disulfide glutathione levels in hippocampus

Donahue, A., Aschner, M., Lash, L. H., Syversen, T. L. M., & Sonntag, W. E. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.003 · Cited by 45

Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia

Fiebich, B. L., Lieb, K., Kammerer, N., & Hüll, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01822.x · Cited by 44

Micronutrients and Alzheimer's disease

Staehelin, H. B. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2005459 · Cited by 44

Metal homeostasis in Alzheimer’s disease

White, A. R., Barnham, K. J., & Bush, A. I. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.5.711 · Cited by 42

Implication of Altered Redox Regulation by Antioxidant Enzymes in the Increased Plasma Pentosidine, an Advanced Glycation End Product, in Uremia

Ueda, Y., Miyata, T., Hashimoto, T., Yamada, H., Izuhara, Y., Sakai, H., & Kurokawa, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8523 · Cited by 40

The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared

Gsell, W., Strein, I., & Riederer, P. F. (1996) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6892-9_5 · Cited by 38

Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules.

González, C., Farias, G. A., & Maccioni, R. B. (1998) · PubMed · Cited by 30

Determination of Glycation Crosslinking by the Sugar-Dependent Incorporation of [14C]Lysine into Protein

Prabhakaram, M., & ORTWERTH, B. J. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1046 · Cited by 29

Glycation

Colaco, C. A. L. S., & Harrington, C. R. (1994) · Neuroreport · doi:10.1097/00001756-199404000-00001 · Cited by 25

Tau glycation is involved in aggregation of the protein but not in the formation of filaments.

Ledesma, M. D., Pérez, M., Colaco, C. A. L. S., & Ávila, J. (1998) · PubMed · Cited by 25

In vivo phosphorylation in the rat basal nucleus induces PHF-like and APP immunoreactivity

Arendt, T., Hanisch, F., Holzer, M., & Bruckner, M. K. (1994) · Neuroreport · doi:10.1097/00001756-199406000-00027 · Cited by 23

Preliminary characterization of bovine pineal prolactin releasing (PPRF) and release-inhibiting factor (PPIF) activity

Chang, N., EBELS, I., & Benson, B. (1979) · Journal of Neural Transmission · doi:10.1007/bf01250335 · Cited by 23

Neue Hypothese zur Ätiopathogenese des Alzheimer-Syndroms Advanced glycation endproducts (AGEs)

Thome, J., Kornhuber, J., Münch, G., Schinzel, R., Taneli, Y., Zielke, B., Rösler, M., & Riederer, P. (1996) · Der Nervenarzt · doi:10.1007/s001150050073 · Cited by 19

Neurochemical abnormalities in Alzheimer’s disease and Parkinson’s disease — a comparative review

Gsell, W., Strein, I., Krause, U., & Riederer, P. F. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_12 · Cited by 16

Reversible in vivo phosphorylation of tau induced by okadaic acid and by unspecific brain lesion in rat.

Janke, C., Gärtner, U., Holzer, M., & Arendt, T. (1998) · PubMed · Cited by 10

Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications

Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 806

Brain metabolic dysfunction at the core of Alzheimer's disease

de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 472

Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders

Singh, S. K., Srivastav, S., Castellani, R. J., Plascencia‐Villa, G., & Perry, G. L. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00767-8 · Cited by 428

Amyloid Beta in Aging and Alzheimer’s Disease

Sehar, U., Rawat, P., Reddy, A. P., Kopel, J. J., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112924 · Cited by 409

Heavy Metals Exposure and Alzheimer’s Disease and Related Dementias

Bakulski, K. M., Seo, Y. A., Hickman, R. C., Brandt, D. J., Vadari, H. S., Hu, H., & Park, S. K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200282 · Cited by 361

Investigations on oxidative stress and therapeutical implications in dementia

Durany, N., Münch, G. W., Michel, T. M., & Riederer, P. F. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014177 · Cited by 86

Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability

Uddin, M. S., & Kabir, M. T. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_5 · Cited by 49

Euro Neuropharmacology 2018: The oxidative stress initiated mitochondrial DNA over proliferation and deletion in the context of the cancer and neurodegeneration: Recent challenge in Neuropharmacology - Gjumrakch Aliev - University of Atlanta

Aliev, G. M. (2020) · Journal of Clinical Medicine and Therapeutics

Oxidativer Streß in der Pathogenese von Morbus Alzheimer und antioxidative Neuroprotektion

Behl, C., & Holsboer, F. (1998) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-995246 · Cited by 39

Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer’s disease — a target for neuroprotective treatment strategies?

Münch, G. W., Deuther‐Conrad, W., & Gasic‐Milenkovic, J. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_28 · Cited by 44